Evithe Biotechnology

Evithé Biotechnology is a New Zealand Food Technology platform commercialising Carelwon®, a patented bioactivated ginger concentrate — the most powerful natural anti-inflammatory and longevity product ever developed. Up to 105× more potent than standard ginger, curcumin, and berberine across six inflammatory pathways, and 13× stronger than CBD in the gold-standard preclinical arthritis model. Three granted patents span 53 countries and 100+ indications. Phase 1 safety and tolerability confirmed (MRINZ, n=50). Evithé targets 'inflamaging' in the global longevity market (USD $65B, 25% CAGR to $314B by 2030). Evithé is raising NZ$3M Pre-Series A to fund DTC launch and B2B acceleration.